These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 3051590)

  • 1. Histologic findings in acute renal allograft rejection with triple drug immunosuppressive therapy: a retrospective analysis.
    Moreno RF; Pallardo LM; Garcia J; Sanchez J; Rochera A; Cabezuelo J; de Agustin PP
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):5-6. PubMed ID: 3051590
    [No Abstract]   [Full Text] [Related]  

  • 2. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E; Robinson C; Bear R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of corticosteroid therapy for acute renal allograft rejection.
    Vineyard GC; Fadem SZ; Dmochowski J; Carpenter CB; Wilson RE
    Surg Gynecol Obstet; 1974 Feb; 138(2):225-9. PubMed ID: 4589909
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of rejection of transplanted organs.
    Keown PA; Stiller CR
    Adv Intern Med; 1986; 31():17-46. PubMed ID: 3511616
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppressive effect of deoxyspergualin on acute renal allograft rejection in dogs.
    Fukao K; Otsuka M; Iwasaki H; Yuzawa K; Iwasaki Y
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1090-3. PubMed ID: 2650068
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss.
    Isoniemi H; Kyllönen L; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Ahonen J
    Transplant Proc; 1995 Feb; 27(1):875-7. PubMed ID: 7879216
    [No Abstract]   [Full Text] [Related]  

  • 8. Early acute kidney allograft rejection in patients with triple-drug immunosuppressive treatment.
    Isoniemi H; Eklund B; Häyry P; Höckerstedt K; Korsbäck C; von Willebrand E; Ahonen J
    Transplant Proc; 1988 Jun; 20(3):447-8. PubMed ID: 3289182
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of cyclosporine A in the treatment of acute renal allograft rejection.
    Gascon M; Donnelly S; Lowry RP
    Transplant Proc; 1987 Aug; 19(4):3481-5. PubMed ID: 3303519
    [No Abstract]   [Full Text] [Related]  

  • 10. Postoperative radionuclide monitoring of renal allografts on triple therapy.
    Thomsen HS; Løkkegaard H; Nielsen SL; Larsen S
    Dan Med Bull; 1988 Aug; 35(4):395-7. PubMed ID: 3048926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of chronic kidney allograft rejection by cyclosporine.
    Abbud-Filho M; Ramalho HJ; Barberato JB; Corrente JE; Zerati-Filho M; Verona CB; Martucci RC; Bezas AG
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1660-2. PubMed ID: 2652544
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of immunosuppressive problems in renal allograft recipients.
    Lorber MI; Flechner SM; Van Buren CT; Sorensen K; Kerman RH; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1951-4. PubMed ID: 3547899
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppressive conversion from cyclosporine A to azathioprine in renal transplant patients.
    Paraiso AR; Ona ET; Alano FA; Ramos CP; De Luna M
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1627. PubMed ID: 2652530
    [No Abstract]   [Full Text] [Related]  

  • 14. Discontinuation of one drug in triple drug treatment of renal allograft patients: 1-year results.
    Isoniemi H; Eklund B; Höckerstedt K; Korsbäck C; Salmela K; von Willebrand E; Häyry P; Ahonen J
    Transplant Proc; 1990 Aug; 22(4):1365-6. PubMed ID: 2202111
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
    Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
    Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
    [No Abstract]   [Full Text] [Related]  

  • 16. Triple therapy and initial renal graft perfusion.
    Thomsen HS; Nielsen SL
    Dan Med Bull; 1988 Aug; 35(4):393-5. PubMed ID: 3048925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphokine responses in renal transplant recipients.
    MacSween JM; Cohen AD; Rajaraman K; Fox RA
    Transplant Proc; 1982 Dec; 14(4):665-8. PubMed ID: 6762723
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive drugs used in clinical renal transplantation.
    Chatterjee SN
    Urology; 1977 Jun; 9(6 Suppl):52-60. PubMed ID: 70101
    [No Abstract]   [Full Text] [Related]  

  • 20. The Stanford experience: survival and renal function in the pre-sandimmune era compared to the sandimmune era.
    Hunt SA; Gamberg P; Stinson EB; Oyer PE; Shumway NE
    Transplant Proc; 1990 Jun; 22(3 Suppl 1):1-5. PubMed ID: 2349732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.